GBA1 and Parkinson disease: There are several potential factors that could be needed to elevate the risk of alpha-synucleinopathy, as most individuals with heterozygous GBA mutations do not develop LBD, with the estimated risk of developing parkinsonism at 80 years being 9.1% [4].